AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
https://www.zacks.com/stock/news/2251310/angiodynamics-ango-alphavac-gets-fda-nod-for-pe-treatment?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251310
Apr 05, 2024 - AngioDynamics (ANGO) announces the FDA's approval of its AlphaVac F1885 System, which is likely to expand the range of therapy alternatives available to pulmonary embolism patients.
0
PE firm Sycamore Partners exploring offer for Gildan Activewear - report
https://seekingalpha.com/news/4081384-pe-firm-sycamore-partners-exploring-offer-for-gildan-activewear-report?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Mar 19, 2024 - Private equity firm Sycamore Partners considering a bid for Gildan Activewear, discusses financing options with potential lenders, according to Bloomberg...
0
Sanofi unit attracts PE firms seeking €7.5B leveraged financing: Bloomberg
https://seekingalpha.com/news/4080085-sanofi-attracts-pe-firms-seeking-75b-financing?source=feed_sector_healthcare
Mar 15, 2024 - Private equity firms are vying for Sanofi's (SNY) consumer division seeking $8.16B in leveraged financing, one of the largest in recent months. Read more here.
0
Pages: 1
Page 1